drugset / Trial / NCT03335124

The Effect of Vitamin C, Thiamine and Hydrocortisone on Clinical Course and Outcome in Patients With Severe Sepsis and Septic Shock

NCT03335124

Phase 4 Terminated 5 enrolled University Medical Centre Ljubljana
RandomizedParallel-groupDouble-blindTreatment

Summary

The global burden of sepsis is substantial with an estimated 15 to 19 million cases per year; the vast majority of these cases occur in low income countries. New therapeutic approaches to sepsis are desperately required; considering the global burden of sepsis these interventions should be effective, cheap, safe and readily available. The aim is to study the synergistic effect of vitamin C, hydrocortisone and thiamine on survival in patients with severe sepsis and septic shock.

Timeline

Start
2017-09-26
Primary completion
2018-12-01
Completion
2018-12-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Hydrocortisone Other / unclassified 50 mg Intravenous
Subject Thiamine Other / unclassified 200 mg Intravenous
Subject Vitamin C Other / unclassified 1500 mg